UNSPSC 51434807: Fenperate

This classification denotes an antihypertensive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1NJ4DG390G. European Medicines Agency schedules Fenperate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07586MIG. Fenperate generally arises in the molecular formula C25H31NO4.

UNSPSC 51434807 Fenperate, a Commodity code, encompasses pharmaceuticals and medications that state and local governments procure for emergency medical services, public health programs, and institutional healthcare operations. Recent solicitations show state and local bodies buying specific emergency medications—epinephrine, adenosine, diltiazem, labetalol—in measured quantities for fire rescue departments, as well as engaging in multi-state cooperative purchasing for generic pharmaceuticals and over-the-counter products distributed through authorized wholesalers to participating government facilities. The issuing bodies include municipal procurement departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The code sees activity across fire rescue services, state Medicaid and health insurance programs, and institutional healthcare networks operated by local and state governments.

Geographic activity spans Florida, Texas, and Minnesota with multi-state cooperative reach into Oregon. The City of Tampa's Purchasing Department posted an IFB (Bid No. 26-P-00188) on April 24, 2026, seeking Advanced Life Support Medications for Tampa Fire Rescue with a response deadline of April 8, 2026 and an estimated contract value of $40,000, designating a 5 percent small local business enterprise (SLBE) sheltered market. The Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026, to gather vendor information on direct-to-manufacturer prescription programs as a preliminary market-intelligence step before formal procurement. MMCAP's RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products closed March 26, 2026, and targets July 1, 2026, contract effectiveness with awards to be distributed to authorized wholesalers including AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson. Performance requirements include FDA compliance, cGMP and Drug Supply Chain Security Act certification, expiration-date minimums (nine months for fire rescue medications, one year for cooperative purchasing), and safety documentation including Safety Data Sheets and WCAG 2.2 accessibility reports where applicable.